Nucletron Corporation Brachytherapy products

Nucletron Corporation 5/21/97 Brachytherapy products

b. Specific versions of Veriflex software are ordered, but no SOPs exist which require verification of the version received. Furthermore, the Purchase Order database, used to check incoming components against part numbers, lists obsolete software versions under the current part number.

3. Failure to follow complaint procedures and to maintain complete complaint files, as the files did not always contain required documentation or the reply to the complainant. For example, complaints involving errors in Veriflex software are fixed and reported to customers in technical bulletins for the next released version of the software. However, not all complaints resolved by a particular version of the software are reported to the customers in these technical bulletins. For example, complaint report 30-951200101 was corrected in Veriflex version 2.02, but was not reported to the customers in the technical bulletin for version 2.02.

4. Failed to maintain complete written failure investigation records, including records of the investigation, conclusions, and follow-up regarding Veriflex system software failures to meet performance specifications after the device had been released for distribution. For example, the “Test Plans” for the validation of Veriflex software corrections do not correspond to the “Test Cases” and complaint numbers in the “Test Reports.”

5. Failure to perform adequate finished product testing for Veriflex version 2.05, in that the software testing for this version did not fully test the software under simulated conditions of use. For example, the software testing to correct the software errors covered by Device Complaint Report #30-163, “Continuous log printing not printing wedge MU’s” covered only expected operational conditions. There was no testing of error conditions, negative testing, or boundary condition testing.

About the author

Amy enjoys researching and writing about developments in medical technology and how that intersects with US law. She received her J.D. from the University of Florida Levin College of Law in 2020 and now works as a Regulatory Associate for SoftwareCPR®, a general-purpose regulatory consulting firm that is recognized globally for their expertise with standards and national regulations pertaining to medical device, mobile medical app, and HealthIT software.

SoftwareCPR Training Courses:

IEC 62304 and other emerging standards for Medical Device and HealthIT Software

Our flagship course for preparing regulatory, quality, engineering, operations, and others for the activities and documentation expected for IEC 62304 conformance and for FDA expectations. The goal is to educate on the intent and purpose so that the participants are able to make informed decisions in the future.  Focus is not simply what the standard says, but what is meant and discuss examples and approaches one might implement to comply.  Special deep discount pricing available to FDA attendees and other regulators.

3-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Brian Pate

Next public offering:  TBD

Email training@softwarecpr.com to request a special pre-registration discount.  Limited number of pre-registration coupons.

Registration Link:

TBD

 


 

Being Agile & Yet Compliant (Public or Private)

Our SoftwareCPR unique approach to incorporating agile and lean engineering to your medical device software process training course is now open for scheduling!

  • Agile principles that align well with medical
  • Backlog management
  • Agile risk management
  • Incremental and iterative software development lifecycle management
  •  Frequent release management
  • And more!

2-days onsite (4 days virtual) with group exercises, quizzes, examples, Q&A.

Instructors: Mike Russell, Ron Baerg

Next public offering: March 7 & 28, 2024

Virtual via Zoom

Registration Link:

Register Now

 


 

Medical Device Cybersecurity (Public or Private)

This course takes a deep dive into the US FDA expectations for cybersecurity activities in the product development process with central focus on the cybersecurity risk analysis process. Overall approach will be tied to relevant standards and FDA guidance documentation. The course will follow the ISO 14971:2019 framework for overall structure but utilize IEC 62304, IEC 81001-5-1, and AAMI TIR57 for specific details regarding cybersecurity planning, risk characterization, threat modeling, and control strategies.

2-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Dr Peter Rech, 2nd instructor (optional)

Next public offering:  TBD

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.